Harvard BioScience, Inc. (NASDAQ:HBIO) develops, manufactures, and markets scientific instruments, systems, and innovative, enabling tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Spun out of Harvard Medical School as Harvard Apparatus in 1901, the company began using the name Harvard Bioscience in the early 1980's before legally changing the company's name in 2000. With a very active acquisition strategy, Harvard Bioscience has a large number of subsidiaries throughout the United States and Europe. The companyâs products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plates for serum protein binding assays; organ testing systems; infusion pumps for infusing small quantities of liquid; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. Its molecular biology products consist of molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, amino acid analysis systems, liquid dispensers, and gel electrophoresis systems, as well as liquid handling consumables primarily comprising pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. Harvard Bioscience, Inc. also distributes various devices, instruments, and consumable items used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; develops devices used by clinicians and researchers in the field of regenerative medicine, including bioreactors for growing tissue and organs outside the body, and injectors for stem cell therapy; and manufactures microdialysis products for in vivo sampling and monitoring of organs and tissue
